RECRUITING

Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease

Talk to us

Conditions

Peripheral Arterial Disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The objective of this study is to determine if using Fuzzy Wale compression stockinet can assist in reducing the healing time and decrease costs in transtibial amputation patients as compared to standard of care treatment compression stocking.

Official Title

A Pilot Study of Fuzzy Wale Compression Stockinet to Evaluate Healing Following Transtibial Amputation for Peripheral Arterial Disease

Quick Facts

Study Start:2025-07-07
Study Completion:2025-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06308562

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * \>18 years
  2. * Male and female
  3. * Transtibial amputation expected.
  4. * Peripheral arterial disease and Transcutaneous partial pressure of oxygen (TCP02, if performed)
  5. * Ability of subject to give appropriate consent or have an appropriate representative available to do so.
  1. * Known allergies to any of the components of the compression.
  2. * Terminal illness or current cancer therapy with chemotherapy
  3. * Inability to undergo ongoing care in Rochester.
  4. * Lack of cognitive ability to follow instructions or monitor residual limb.
  5. * Vulnerable study population
  6. * Pregnancy

Contacts and Locations

Study Contact

Vascular Research Team
CONTACT
(507) 538-7425
Melin.Matthew@mayo.edu
Matthew Melin, M.D.
CONTACT
(507) 266-6717
Melin.Matthew@mayo.edu

Principal Investigator

Matthew Melin, M.D.
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Matthew Melin, M.D., PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-07
Study Completion Date2025-12

Study Record Updates

Study Start Date2025-07-07
Study Completion Date2025-12

Terms related to this study

Additional Relevant MeSH Terms

  • Peripheral Arterial Disease